Zydus Lifesciences Q4 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
1,087.05
1.60 (0.15%)
1.60 (0.15%)Volume1.06 L
Updated: Fri 5 Jun, 2026 | 15:29:45
NSE
1,089.004.40 (0.41%)
4.40 (0.41%)Volume9.19 L
Updated: Fri 5 Jun, 2026 | 15:41:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹7,587.00 Cr.(16.22%)
- Operating Profit₹1,003.60 Cr.(-41.22%)
- Profit After Tax₹1,272.50 Cr.(8.68%)
- Operating Margin13.23%(-49.43%)
Note: Comparison is on YoY basis
Quarterly - Zydus Lifesciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,583.40 | 5,657.00 | 16.38% | 4,113.90 | 36.57% |
| Depreciation/ Amortization | 508.40 | 359.60 | 41.38% | 205.30 | 113.70% |
| Operating Income | 1,003.60 | 1,207.50 | -16.89% | 1,419.90 | -41.22% |
| Net Income | 1,272.50 | 1,042.10 | 22.11% | 1,182.30 | 8.68% |
| Other Operating Expenses Total | 2,462.40 | 2,236.50 | 10.10% | 1,460.10 | 45.32% |
| Net Income Before Taxes | 1,659.70 | 1,353.40 | 22.63% | 1,547.00 | -0.74% |
| Total Revenue | 7,587.00 | 6,864.50 | 10.53% | 5,533.80 | 16.22% |
| Selling/ General/ Admin Expenses Total | 1,238.80 | 1,139.70 | 8.70% | 837.00 | 27.53% |
| Diluted Normalized EPS | 15.84 | 10.96 | 44.53% | 11.56 | 19.44% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.